This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Last week, the US FDA held a meeting to decide if a new surrogate endpoint (Minimal Residual Disease or MRD negativity) could be used to give more & faster drug approvals for patients with newly diagnosed multiple myeloma. Multiple myeloma drugs can cost $600,000 per year of treatment, but if MRD is permitted for drug approval, I suspect we will see a deluge of uncertain drugs added to the roster, and the costs per year per patient will swell to a million dollars or more.
A recent investigation in Quebec uncovered a concerning trend: benzodiazepines — medications commonly used for sleep or anxiety — are being overprescribed. This investigation has prompted the Quebec College of Physicians to closely examine the usage of these medications. But this issue extends beyond Quebec’s borders; across Canada, these medications are being prescribed at alarming rates.
In the past few years, what event or innovation has had the metaphorical impact of hitting you upside the head and disrupted your best-laid plans in health care? A few such forces for me have been the COVID-19 pandemic, the emergence of Chat-GPT, and Russia’s invasion of Ukraine. That’s just three, and to be sure, there are several others that have compelled me to shift my mind-set about what I thought I knew-I-knew for my work with organizations spanning the health care ecosystem.
By Rose O. Sherman, EdD, RN, NEA-BC, FAAN Last week, I gave the AONL Research Foundation Keynote at the AONL meeting in New Orleans. My topic was the Evolving Role of Nurse Managers in the New World of Work. To prepare for this presentation, we sought input from nurse managers through five focus groups conducted […] The post Improving the Work-Lives of Nurse Managers appeared first on Emerging Nurse Leader.
According to a recent report by the Stanford-Lancet Commission on the North American Opioid Crisis, “more than 600,000 people in the USA and Canada have died from opioid overdose since 1999, and a staggering 1.2 million more are estimated to die due to overdose by 2029.” The opioid crisis has reinforced hard lessons learned in Read more… Saving lives with naloxone: perspectives from the frontline originally appeared in KevinMD.com.
According to a recent report by the Stanford-Lancet Commission on the North American Opioid Crisis, “more than 600,000 people in the USA and Canada have died from opioid overdose since 1999, and a staggering 1.2 million more are estimated to die due to overdose by 2029.” The opioid crisis has reinforced hard lessons learned in Read more… Saving lives with naloxone: perspectives from the frontline originally appeared in KevinMD.com.
52
52
Input your email to sign up, or if you already have an account, log in here!
Enter your email address to reset your password. A temporary password will be e‑mailed to you.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
363 
Let's personalize your content